Regeneron’s Inmazeb gets FDA approval for Ebola treatment

This article was originally published here

Inmazeb, which was previously called REGN-EB3, is now the first treatment to have been approved by the FDA for Ebola. The antibody cocktail has been indicated for the

The post Regeneron’s Inmazeb gets FDA approval for Ebola treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply